1. Home
  2. GKOS vs SITM Comparison

GKOS vs SITM Comparison

Compare GKOS & SITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • SITM
  • Stock Information
  • Founded
  • GKOS 1998
  • SITM 2003
  • Country
  • GKOS United States
  • SITM United States
  • Employees
  • GKOS N/A
  • SITM N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • SITM Semiconductors
  • Sector
  • GKOS Health Care
  • SITM Technology
  • Exchange
  • GKOS Nasdaq
  • SITM Nasdaq
  • Market Cap
  • GKOS 5.8B
  • SITM 5.3B
  • IPO Year
  • GKOS 2015
  • SITM 2019
  • Fundamental
  • Price
  • GKOS $94.32
  • SITM $190.16
  • Analyst Decision
  • GKOS Strong Buy
  • SITM Strong Buy
  • Analyst Count
  • GKOS 12
  • SITM 5
  • Target Price
  • GKOS $134.67
  • SITM $228.00
  • AVG Volume (30 Days)
  • GKOS 869.3K
  • SITM 347.1K
  • Earning Date
  • GKOS 07-30-2025
  • SITM 08-06-2025
  • Dividend Yield
  • GKOS N/A
  • SITM N/A
  • EPS Growth
  • GKOS N/A
  • SITM N/A
  • EPS
  • GKOS N/A
  • SITM N/A
  • Revenue
  • GKOS $404,523,000.00
  • SITM $229,989,000.00
  • Revenue This Year
  • GKOS $27.88
  • SITM $38.21
  • Revenue Next Year
  • GKOS $27.60
  • SITM $23.79
  • P/E Ratio
  • GKOS N/A
  • SITM N/A
  • Revenue Growth
  • GKOS 23.92
  • SITM 65.85
  • 52 Week Low
  • GKOS $77.10
  • SITM $105.40
  • 52 Week High
  • GKOS $163.71
  • SITM $268.18
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 37.61
  • SITM 37.35
  • Support Level
  • GKOS $92.42
  • SITM $189.27
  • Resistance Level
  • GKOS $98.21
  • SITM $200.00
  • Average True Range (ATR)
  • GKOS 2.85
  • SITM 8.56
  • MACD
  • GKOS -1.10
  • SITM -2.41
  • Stochastic Oscillator
  • GKOS 13.19
  • SITM 3.45

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SITM SiTime Corporation

SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.

Share on Social Networks: